Where is Cdrd.ca located?

Cdrd.ca is headquartered in Vancouver, Canada.

Where does Cdrd.ca rank among its competitors?

Cdrd.ca ranks 62nd amongst 225 active competitors, of which 4 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was BioMADE, which secured $2.42M in Aug, 2025.

Who are the top competitors of Cdrd.ca?

Cdrd.ca's top competitors include Vial, Javara Research and Alcanza Clinical Research. Among them, BioMADE secured the most recent funding round in August, 2025.

Cdrd.ca - 2026 Company Profile & Competitors

Most viewed in 2019

Cdrd.ca is an unfunded company based in Vancouver (Canada), founded in 2004. It operates as a Provides research site for drug development. Cdrd.ca has not raised any funding yet. The company has 225 active competitors, including 4 funded and 29 that have exited. Its top competitors include companies like Vial, Javara Research and Alcanza Clinical Research.

Key Metrics

Founded Year

2004

Location

Vancouver, Canada

Stage

Unfunded

Ranked

62^nd among 225 active competitors

Investment & Acquisitions

Sitka Biopharma & 2 more

Similar Companies

Vial & 269 more

View Cdrd.ca's full profile

Cdrd.ca has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cdrd.ca include Vial, Javara Research and Alcanza Clinical Research. Here is the list of Top 10 competitors of Cdrd.ca, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Vial 2020, San Francisco (United States), Series B	-	$100M	General Catalyst, BoxGroup & 1 others	51/100
2nd	Javara Research 2018, Winston-salem (United States), Series B	Integrating clinical research at the point of care for better outcomes	$45M	General Atlantic, Dioko Ventures & 1 others	47/100
3rd	Alcanza Clinical Research 2021, Methuen (United States), Funding Raised	Clinical research site network focused on accelerating the development of new therapies by reducing barriers to participation	-	Impact Engine, Martis Capital	46/100
4th	BioMADE 2020, Saint Paul (United States), Funding Raised	Provider of clinical trial research site services for biopharma sector	-	National Oceanic and Atmospheric Administration, National Science Foundation ... Read more	45/100
5th	Tekton Research 2006, Austin (United States), Acquired	Clinical research site network conducting Phase 1-4 trials across multiple therapeutic areas	-	-	44/100
6th	Care Access 1998, Boston (United States), Unfunded	CRO offering clinical sites which conduct clinical trials	-	-	43/100
7th	The START Center for Cancer Research 2007, San Antonio (United States), Series B	Provider of early-phase oncology clinical trials and research services	$16.9M	Warburg Pincus	42/100
8th	Evolution Research Group 2015, Watchung (United States), Acquired	Clinical research organization conducting trials for various medical conditions and healthy volunteers	-	DFW Capital Partners	42/100
9th	Summit Clinical Research 2018, San Antonio (United States), Acquired	CRO providing research site for clinical development services	-	LongueVue Capital	41/100
10th	Tilda Bio 2017, San Francisco (United States), Funding Raised	Provider of clinical trial execution services to sponsors and CROs	-	Storm Ventures, 8VC	39/100
62nd	Cdrd.ca 2004, Vancouver (Canada), Unfunded	Provides research site for drug development	-	-	25/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Cdrd.ca's competitors? Click here to see the top ones

Cdrd.ca has made 3 investments including Sitka Biopharma, Zucara Therapeutics and Zucara Therapeutics. Cdrd.ca has not made any acquisitions as of now.

Here is the list of its investments:

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Feb 11, 2019	Investments	Sitka Biopharma	2013	Vancouver (Canada)
Feb 09, 2018	Investments	Zucara Therapeutics	2015	Vancouver (Canada)
Nov 03, 2016	Investments	Zucara Therapeutics	2015	Vancouver (Canada)